Losing weight through lifestyle changes can significantly improve several measures of nonalcoholic fatty liver disease, particularly if patients lose at least 10% of their body weight, and bariatric...
Clinicians and researchers must get better at identifying Lynch syndrome because the diagnosis is so often missed, according to new American Gastroenterological Association clinical guidelines for...
Patients with human papillomavirus–related oropharyngeal carcinoma (HPV-OPC) who had human papillomavirus type 16 (HPV16) detected in oral rinses both at diagnosis and at any time after treatment...
Eradicating Helicobacter pylori bacteria with a short course of antibiotics and proton pump inhibitors helped reduce the risk of gastric cancer in otherwise healthy and asymptomatic H....
The U.S. Food and Drug Administration has approved Daklinza (daclatasvir), a hepatitis C virus (HCV) drug that, when used in combination with sofosbuvir, does not require coadministration of...
The first interferon-free treatment for people with genotype 4 hepatitis C infection has been approved by the Food and Drug Administration.
On July 24, the FDA approved a combination of three...
With assistance from the Centers for Disease Control and Prevention, the country of Georgia has launched a hepatitis C elimination program aimed at reducing disease transmission and meeting increased...
Treatment with ledipasvir and sofosbuvir achieves sustained virologic response at 12 weeks in patients with hepatitis C who also are infected with HIV, according to the results of the open-label...
Patients treated with daclatasvir and sofosbuvir for hepatitis C who are coinfected with HIV have shown a significant virologic response, regardless of whether they had already been treated for their...
Once again, gastroenterologists are preparing to challenge the Centers for Medicare & Medicaid Services (CMS) on proposed cuts to reimbursement for colonoscopies and related services.
The...
